Quote | MedTech Acquisition Corporation (NASDAQ:MTAC)
Last: | $11.34 |
---|---|
Change Percent: | 2.15% |
Open: | $9.35 |
Close: | $11.34 |
High: | $12.8299 |
Low: | $8.96 |
Volume: | 178,443 |
Last Trade Date Time: | 08/10/2023 03:00:00 am |
News | MedTech Acquisition Corporation (NASDAQ:MTAC)
2023-08-09 12:57:34 ET MedTech Acquisition Corp. ( NASDAQ: MTAC ) shareholders have voted in favor of the SPAC's planned merger with oncology products developer TriSalus Life Sciences. MTAC disclosed the vote in a filing. After the closing, shares of the combined company are...
MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting is being hel...
Message Board Posts | MedTech Acquisition Corporation (NASDAQ:MTAC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
MedTech Acquisition Corporation Company Name:
MTAC Stock Symbol:
NASDAQ Market:
MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or the “Company”) today announced that it convened and then adjourned, without conducting any business, its special meeting of stockholders (the “Special Meeting”). The Special Meeting is being hel...
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment and decreased circulating tumor DNA (ctDNA) levels TriSalus Life Sciences® Inc., (TriSalus or the Company), an oncology company in the process of going publi...
TriSalus Life Sciences ® , Inc. (“TriSalus” or the “Company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“...